athenahealth Inc (ATHN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:athenahealth Inc (ATHN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9761
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
athenahealth Inc (athenahealth) is a provider of cloud-based business services and mobile applications for medical groups and health system. The company offers network-enabled services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, population health management, and care coordination as well as Epocrates and other point-of-care mobile applications. It offers industrial solutions to medical groups and practices, hospitals and health systems, medical specialties, federally qualified health centers, accountable care organizations, academic medical centers, community hospitals and for starting a medical practice. The company operates through subsidiaries in Massachusetts, Georgia, North Carolina, Maine, Delaware in the US and Chennai in India. athenahealth is headquartered in Watertown, Massachusetts, the US.

athenahealth Inc (ATHN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
athenahealth Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
athenahealth Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
athenahealth Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
athenahealth Inc, Medical Devices Deals, 2012 to YTD 2018 8
athenahealth Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
athenahealth Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
RubiconMD Secures USD1.3 Million in Venture Funding 10
Partnerships 11
Cerner and athenahealth Enter into Agreement with Apple 11
Acquisition 12
athenahealth Completes Acquisition of Epocrates, Healthcare IT Company, For US$293 Million 12
athenahealth Inc – Key Competitors 14
athenahealth Inc – Key Employees 15
athenahealth Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Financial Announcements 18
Jul 30, 2018: Athenahealth reports second quarter fiscal year 2018 results 18
Corporate Communications 19
Jun 06, 2018: athenahealth Initiates Process to Explore Strategic Alternatives, Including Search for New Chief Executive Officer 19
Other Significant Developments 21
Feb 15, 2017: athenahealth’s Health Plan Data Exchange Service Enables Data Exchange Between Providers and Health Plans 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
athenahealth Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
athenahealth Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
athenahealth Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
athenahealth Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
athenahealth Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
athenahealth Inc, Medical Devices Deals, 2012 to YTD 2018 8
athenahealth Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
RubiconMD Secures USD1.3 Million in Venture Funding 10
Cerner and athenahealth Enter into Agreement with Apple 11
athenahealth Completes Acquisition of Epocrates, Healthcare IT Company, For US$293 Million 12
athenahealth Inc, Key Competitors 14
athenahealth Inc, Key Employees 15
athenahealth Inc, Other Locations 16
athenahealth Inc, Subsidiaries 16

List of Figures
athenahealth Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
athenahealth Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
athenahealth Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
athenahealth Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
athenahealth Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
athenahealth Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
athenahealth Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[athenahealth Inc (ATHN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cimarex Energy Co.:企業の戦略・SWOT・財務分析
    Cimarex Energy Co. - Strategy, SWOT and Corporate Finance Report Summary Cimarex Energy Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Galapagos NV (GLPG):企業の財務・戦略的SWOT分析
    Summary Galapagos NV (Galapagos) is a biotechnology company that discovers and develops small molecule medicines. The company’s clinical pipeline include filgotinib, which is in Phase III clinical trials for the treatment of rheumatoid arthritis and Crohn’s disease, Phase 2 and 3 trials for ulcerati …
  • Green Cross LabCell Corp (144510):製薬・医療:M&Aディール及び事業提携情報
    Summary Green Cross LabCell Corp (GCLabCell), a subsidiary of GC Pharma, is a biotechnology company that offers biopharmaceuticals. The company’s products include specialty medicines, blood products and vaccines, generic drugs, parenteral products, and genetically-modified hemophilia A drug Greenjun …
  • Medical Depot Inc-医療機器分野:企業M&A・提携分析
    Summary Medical Depot Inc (Drive Medical) is a medical device company that manufactures and markets mobility products. The company offers products such as rollators, walkers, canes and crutches; bath safety, commodes, wheelchairs, patient room, beds, power mobility, pressure prevention, electrothera …
  • Daisy IT Group Ltd:企業の戦略的SWOT分析
    Daisy IT Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Origin Enterprises PLC:企業のM&A・事業提携・投資動向
    Origin Enterprises PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Origin Enterprises PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Duravit AG:企業の戦略・SWOT・財務情報
    Duravit AG - Strategy, SWOT and Corporate Finance Report Summary Duravit AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Life Time Fitness, Inc:企業の戦略・SWOT・財務情報
    Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report Summary Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • China Huaneng Group:発電所・企業SWOT分析
    China Huaneng Group - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • American CryoStem Corp (CRYO):医療機器:M&Aディール及び事業提携情報
    Summary American CryoStem Corp (American CryoStem), formerly Advanced Wound Technologies-MidAtlantic LLC is a manufacturer, developer, and marketer of life-enhancing and stem cell technologies. The company offers products such as adipose derived stem cells, tissue collection and transportation produ …
  • Semperit AG Holding (SEM):企業の財務・戦略的SWOT分析
    Summary Semperit AG Holding (Semperit) is a developer, manufacturer and marketer of rubber products for the medical and industrial sectors. The company’s products comprise surgical gloves, examination gloves and reusable protective gloves. It also offers hydraulic hoses, industrial hoses, rubber she …
  • Highmark Inc.:企業の戦略・SWOT・財務情報
    Highmark Inc. - Strategy, SWOT and Corporate Finance Report Summary Highmark Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Zebra Technologies Corp (ZBRA):企業の財務・戦略的SWOT分析
    Zebra Technologies Corp (ZBRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Arm Cement Plc:企業の戦略・SWOT・財務情報
    Arm Cement Plc - Strategy, SWOT and Corporate Finance Report Summary Arm Cement Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • BSN medical GmbH-医療機器分野:企業M&A・提携分析
    Summary BSN medical GmbH (BSN medical) is healthcare company specialized in compression therapy, wound care and othropedics. It manufactures and markets medical products for wound care and related vascular diseases, lumphology and non-invasive orthopedic products. The company's product line includes …
  • Entercom Communications Corp (ETM):企業の財務・戦略的SWOT分析
    Summary Entercom Communications Corp (Entercom) is a provider of media and entertainment services. The company offers radio broadcasting programs. It owns and operates radio stations in various formats, including classic rocks, sports, news, talk, adult contemporary, alternative and country and othe …
  • Deciphera Pharmaceuticals LLC (DCPH)-製薬・医療分野:企業M&A・提携分析
    Summary Deciphera Pharmaceuticals LLC (Deciphera Pharmaceuticals) is a research and development company that develops, designs, and commercializes kinase inhibiting drugs. The company's clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It uses pr …
  • Ryanair Holdings plc:企業の戦略・SWOT・財務分析
    Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Ryanair Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • TG Therapeutics Inc (TGTX):製薬・医療:M&Aディール及び事業提携情報
    Summary TG Therapeutics Inc (TG Therapeutics) is a biopharmaceutical company which acquires, develops and commercializes pharmaceutical products for the treatment of B-cell malignancies and autoimmune diseases. The company develops two therapies, namely, TG-1101 (ublituximab) and TGR-1202 for the tr …
  • easyJet Plc:企業の戦略・SWOT・財務情報
    easyJet Plc - Strategy, SWOT and Corporate Finance Report Summary easyJet Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆